Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Report 2026

Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Overview

• Optical Coherence Tomography (OCT) For Healthcare And Life Science market size has reached to $2.26 billion in 2025 • Expected to grow to $4.77 billion in 2030 at a compound annual growth rate (CAGR) of 16.1% • Growth Driver: Ocular Disease Surge Fuels OCT Market Growth • Market Trend: Introduction Of Advanced Multi-Function OCT Systems Enhancing Clinical Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Optical Coherence Tomography (OCT) For Healthcare And Life Science Market?

Optical coherence tomography (OCT) is a non-invasive imaging technique that uses light to capture high-resolution cross-sectional images of tissues. It is widely used in ophthalmology to view the retina and detect eye conditions, and it also has applications in other medical fields for detailed tissue imaging and assessment. It provides high-resolution, non-invasive imaging of tissues, offering detailed insights for diagnosing and monitoring conditions in ophthalmology and other medical fields. The main types of optical coherence tomography (OCT) for healthcare and life science include catheter-based optical coherence tomography (OCT) devices, doppler optical coherence tomography (OCT) devices, handheld optical coherence tomography (OCT) devices, and tabletop optical coherence tomography (OCT) devices. Catheter-based OCT devices are imaging tools used in medical procedures that allow for high-resolution imaging of blood vessels and internal structures during minimally invasive procedures. The technologies include time domain OCT (TdOct), frequency domain OCT (FdOct), and others for applications that include ophthalmology, cardiology, dermatology, gastroenterology, and others. The end users include hospitals, specialty clinics, research institutes, and others.

What Is The Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Growth Forecast?

The optical coherence tomography (oct) for healthcare and life science market size is expected to see rapid growth in the next few years. It will grow to $4.77 billion in 2030 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to increasing demand for point-of-care diagnostics, rising adoption in cardiology and dermatology, expansion of tele-ophthalmology services, growing investments in imaging technology innovation, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of ai-assisted image analysis, rising demand for high-resolution non-invasive imaging, growing use of portable and handheld oct devices, expansion of oct applications beyond ophthalmology, enhanced integration with digital health platforms.

Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Segmentation

1) By Type: Catheter Based Optical Coherence Tomography (OCT) Devices, Doppler Optical Coherence Tomography (OCT) Devices, Handheld Optical Coherence Tomography (OCT) Devices, Tabletop Optical Coherence Tomography (OCT) Devices 2) By Technology: Time Domain Oct (TdOct), Frequency Domain Oct (FdOct), Other Technologies 3) By Application: Ophthalmology, Cardiology, Dermatology, Gastroenterology, Other Applications 4) By End Users: Hospitals, Specialty Clinics, Research Institutes, Other End Users Subsegments: 1) By Catheter Based Optical Coherence Tomography (OCT) Devices: Intravascular OCT (IV-OCT), Endoscopic OCT, Other Catheter-Based Devices 2) By Doppler Optical Coherence Tomography (OCT) Devices: Speckle-Tracking Doppler OCT, Phase-Resolved Doppler OCT 3) By Handheld Optical Coherence Tomography (OCT) Devices: Portable Handheld OCT Systems, Compact Handheld Devices 4) By Tabletop Optical Coherence Tomography (OCT) Devices: Standalone Tabletop Systems, Modular Tabletop Devices

What Is The Driver Of The Optical Coherence Tomography (OCT) For Healthcare And Life Science Market?

The rising incidence of ocular diseases is expected to propel the growth of optical coherence tomography (OCT) for healthcare and life science market going forward. Ocular diseases are disorders that affect the eyes and their surrounding structures, potentially leading to vision impairment or blindness. The ocular diseases are largely attributed to the aging population and the increased prevalence of chronic conditions such as diabetes. Optical coherence tomography (OCT) is used to provide detailed, cross-sectional images of the retina and optic nerve, aiding in diagnosing and monitoring ocular diseases. For instance, according to the report of the Review of Optometry, a US-based publication offering comprehensive insights and updates on eye care, an estimated 80 million people globally are affected by glaucoma, with open-angle glaucoma (OAG) accounting for 95% of cases. In the U.S. alone, more than three million individuals are currently living with the condition. Moreover, the number is projected to exceed 111 million by 2040. Therefore, the rising incidence of ocular diseases will drive the growth of optical coherence tomography (OCT) for healthcare and life science industry.

Key Players In The Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market

Major companies operating in the optical coherence tomography (oct) for healthcare and life science market are Abbott Laboratories, Canon Inc., Carl Zeiss Meditec AG, Leica Microsystems GmbH, Thorlabs Inc., Edmund Optics Inc., Huvitz Co. Ltd., Santec Corporation, Topcon Medical Systems Inc., OPTOPOL Technology SA, NinePoint Medical, Wasatch Photonics Inc., Perimeter Medical Imaging AI Inc., Nidek Co. Ltd., Novacam Technologies Inc., DermaLumics, BaySpec Inc., Imalux Corporation, Lumedica, Heidelberg Engineering GmbH

Global Optical Coherence Tomography (OCT) For Healthcare And Life Science Market Trends and Insights

Major companies operating in the optical coherence tomography (oct) for healthcare and life science market are focusing on developing advanced solutions, such as ophthalmic diagnostic devices, to enhance clinical efficiency. Ophthalmic diagnostic devices are tools designed to evaluate the eyes and identify or monitor vision and eye-related health issues. For instance, in July 2025, Huvitz, a South Korea-based manufacturer of ophthalmic and dental equipment, launched the OCTavius ophthalmic diagnostic device. It is a versatile 5-in-1 OCT system that brings several key eye-diagnostic functions together in one unit, reducing the need for multiple instruments. It improves workflow efficiency by offering quick scans and sharp imaging that support smoother clinical operations. The device captures fine structural details of the macula and choroid, enabling thorough, layer-specific evaluation. These capabilities make it a distinctive tool for early detection and accurate clinical judgment in ophthalmology.

What Are Latest Mergers And Acquisitions In The Optical Coherence Tomography (OCT) For Healthcare And Life Science Market?

In July 2024, EssilorLuxottica SA, a France-based eyewear corporation, acquired an 80% stake in Heidelberg Engineering Inc. for an undisclosed amount. This acquisition strengthens EssilorLuxottica’s med-tech capabilities by integrating advanced optical coherence tomography technologies into its clinical and diagnostic ecosystem. It further enhances the company’s ability to improve patient care and clinical outcomes by expanding its footprint in high-precision ophthalmic imaging. Heidelberg Engineering Inc. is a Germany-based medical equipment company that develops optical coherence tomography devices for healthcare.

Regional Outlook

North America was the largest region in the optical coherence tomography (OCT) for healthcare and life science market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Optical Coherence Tomography (OCT) For Healthcare And Life Science Market?

The optical coherence tomography (OCT) for healthcare and life science markets consists of revenues earned by entities by providing services such as high-resolution imaging and diagnostics for medical conditions, including device sales, maintenance, software solutions, and technical support across various medical fields like ophthalmology, cardiology, and dermatology. The market value includes the value of related goods sold by the service provider or included within the service offering. The optical coherence tomography (OCT) for healthcare and life science markets also includes sales of imaging systems, accessories including lenses and probes, software for data analysis, and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.